Terminated PHASE3 INTERVENTIONAL 2-arm NCT02711241

Optimal Analgesia in Acute Gastroenteritis

Optimal Analgesia in Acute Gastroenteritis in Emergency Department Setting: Dipyrone Versus Papaverine

Sponsor: Hadassah Medical Organization

Updated 5 times since 2017 Last updated: Mar 13, 2016 Started: Jun 30, 2010 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Not enough patients

Other terminated trials from Hadassah Medical Organization

See all terminations from Hadassah Medical Organization

Other Gastroenteritis trials with similar outcome

Browse all Gastroenteritis trials

This PHASE3 trial investigates Gastroenteritis and is currently terminated or withdrawn. Hadassah Medical Organization leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel